Home2162 • HKG
add
Keymed Biosciences Inc
Nakaraang pagsara
$30.25
Sakop ng araw
$29.50 - $30.60
Sakop ng taon
$26.60 - $47.50
Market cap
8.25B HKD
Average na Volume
1.99M
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 27.34M | -83.28% |
Gastos sa pagpapatakbo | 222.20M | 33.65% |
Net na kita | -168.37M | -816.98% |
Net profit margin | -615.82 | -4,388.44% |
Kita sa bawat share | — | — |
EBITDA | -177.90M | -18,577.01% |
Aktuwal na % ng binabayarang buwis | -1.84% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 2.58B | -13.50% |
Kabuuang asset | 3.81B | -6.45% |
Kabuuang sagutin | 1.17B | 68.48% |
Kabuuang equity | 2.64B | — |
Natitirang share | 275.60M | — |
Presyo para makapag-book | 3.16 | — |
Return on assets | -12.92% | — |
Return on capital | -14.51% | — |
Cash Flow
Net change in cash
| (CNY) | Hun 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -168.37M | -816.98% |
Cash mula sa mga operasyon | -182.96M | -1,023.06% |
Cash mula sa pag-invest | -19.93M | -108.97% |
Cash mula sa financing | 131.96M | 6,820.75% |
Net change in cash | -70.56M | -127.61% |
Malayang cash flow | -148.22M | -31.18% |
Tungkol
CEO
Itinatag
Set 2016
Website
Mga Empleyado
1,116
